Clinical Trials Browser

Fibrosis, Carcinoma, Hepatocellular

NCT03520660 2026-03-11

People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents

Phase 4 Active not recruiting

121 enrolled

Gastrointestinal

Cardiovascular Diseases, Diabetes Mellitus, Fibrosis, Hepatitis C, Carcinoma, Hepatocellular, Hepatitis C, Chronic

NCT03654053 2026-01-07

SACRED

Phase 3 Active not recruiting

142 enrolled

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular

NCT05064553 2025-10-15

ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk

Active not recruiting

2,990 enrolled

Gastrointestinal

Fibrosis, Hepatitis B, Carcinoma, Hepatocellular, Liver Neoplasms

NCT02626312 2025-10-14

Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function

Phase 1 Active not recruiting

36 enrolled

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Cholangiocarcinoma

NCT03612531 2025-10-14

MANTLE

Phase NA Active not recruiting

24 enrolled

Deglutition Disorders, Fibrosis

NCT05242900 2025-04-27

Imaging Sodium and Lymphatics in Lymphedema

Active not recruiting

75 enrolled

Fibrosis, Lymphedema, Neoplasm Metastasis

NCT02908048 2025-04-06

Extracellular RNA Markers of Liver Disease and Cancer

Active not recruiting

1,810 enrolled

Gastrointestinal

Bile Duct Neoplasms, Biliary Tract Neoplasms, Fibrosis, Hepatitis, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Cholangiocarcinoma

NCT05586516 2025-03-20

A Study to Assess an ATX Inhibitor (IOA-289) in Patients with Metastatic Pancreatic Cancer

Phase 1/2 Active not recruiting

24 enrolled

Gastrointestinal

Fibrosis, Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

NCT05027425 2024-11-22

Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant

Phase 2 Active not recruiting

30 enrolled

Gastrointestinal

Fibrosis, Carcinoma, Hepatocellular, Hypertension, Portal

NCT03278925 2024-08-02

Defined Green Tea Catechin Extract in Preventing Liver Cancer in Participants With Cirrhosis

Phase 1 Active not recruiting

14 enrolled

Fibrosis

NCT06315361 2024-03-18

DIANA

Active not recruiting

600 enrolled

Gastrointestinal

Diabetes Mellitus, Fibrosis, Liver Cirrhosis, Liver Neoplasms, Non-alcoholic Fatty Liver Disease

NCT02384733 2021-07-08

Hypofractionated Loco-regional Adjuvant Radiation Therapy of Breast Cancer Combined With a Simultaneous Integrated Boost

Phase NA Active not recruiting

2,963 enrolled

Fibrosis, Lymphedema, Recurrence

Clinical Trials

Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis

People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents

SACRED

ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk

Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function

MANTLE

Imaging Sodium and Lymphatics in Lymphedema

Extracellular RNA Markers of Liver Disease and Cancer

A Study to Assess an ATX Inhibitor (IOA-289) in Patients with Metastatic Pancreatic Cancer

Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant

Defined Green Tea Catechin Extract in Preventing Liver Cancer in Participants With Cirrhosis

DIANA

Hypofractionated Loco-regional Adjuvant Radiation Therapy of Breast Cancer Combined With a Simultaneous Integrated Boost